Cancer and Women's Health Interagency Agreement
|
Research Initiative
|
FDA
|
NCI
|
2013
|
|
Cancer Moonshot Blue Ribbon Panel
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, OD/ OSP
|
2016
|
|
CDC and HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
OD/ DPCPSI/ OAR
|
2002
|
|
CDC’s Division of Select Agents and Toxins (DSAT) Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2015
|
|
CDRH Retinal Devices Seminar: Focus on the Patient Experience with Inherited Retinal Degeneration
|
Meeting/ Workshop
|
FDA
|
NEI
|
2016
|
|
Characterize Emerging HIV Strains from Blood Donors and Patients
|
Resource Development
|
FDA
|
NIAID
|
2009
|
|
Chemical Integrated Program Team (IPT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NICHD
|
2008
|
|
Chronic Fatigue Syndrome Advisory Committee (CFSAC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
CSR, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR
|
2003
|
|
Clinical and Translational Research Course for PhD Students
|
Training Initiative
|
FDA
|
CC, NCATS, NCI, NHLBI, NIAID, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NINDS
|
2012
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2009
|
|
Clinical Islet Transplantation Consortium
|
Research Initiative
|
CMS, FDA
|
NIAID, NIDDK
|
2004
|
|
Clinical Trial Designs for Emerging Infectious Diseases
|
Meeting/ Workshop
|
CDC, FDA
|
NIAID
|
2015
|
|
ClinicalTrials.gov
|
Resource Development
|
FDA
|
CC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ OER, OD/ OSP
|
2000
|
|
CMS-FDA-NIH Trilateral Council
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NIA, OD/ OER, OD/ OSP
|
2016
|
|
CMS/CDC/FDA/NIH Opioid Abuse Collaboration
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
NIA, NIDA, NINDS
|
2016
|
|
Collaborative Islet Transplant Registry Ad Hoc Scientific Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
NIAID
|
2009
|
|
Collaborative Use Repurposing Engine (CURE)
|
Research Initiative
|
FDA
|
NCATS
|
2013
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
2000
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
CC
|
2004
|
|
Conducting Comprehensive Toxicological Assessments
|
Research Initiative
|
FDA
|
NIEHS
|
1996
|
|
Consortium for TB Biomarkers (CTB2)
|
Resource Development
|
FDA
|
NIAID
|
2012
|
|
Countermeasures Against Chemical Threats (CounterACT) Research Network
|
Research Initiative
|
CDC, FDA, OS
|
NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS, NLM
|
2006
|
|
Creutzfeldt-Jakob Disease Surveillance in Recipients of Human Growth Hormone, National Hormone and Pituitary Program (NHPP)
|
Resource Development
|
CDC, FDA
|
NIDDK
|
1985
|
|
|